Patents by Inventor Qinwei Wang

Qinwei Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triazine derivatives and their therapeutical applications
    Patent number: 9078902
    Abstract: The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: July 14, 2015
    Assignee: NantBioScience, Inc.
    Inventors: Chunlin Tao, Qinwei Wang, Laxman Nallan, Tulay Polat, David Ho, Neil Desai
  • DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES
    Publication number: 20150190556
    Abstract: The invention provides a medical device comprising a hydrophobic analog of a medicament known to inhibit cell proliferation and migration. The invention also provides a method of treating a narrowing in a body passageway comprising placing an implantable medical device comprising a hydrophobic analog of a medicament known to inhibit cell proliferation and migration. The medicaments can be incorporated within or coated on the device. The invention further provides hydrophobic analogs of medicaments known to inhibit cell proliferation and migration.
    Type: Application
    Filed: March 20, 2015
    Publication date: July 9, 2015
    Inventors: Neil P. Desai, Chunlin Tao, Cheng Zhi Yu, Qinwei Wang, Patrick Soon-Shiong
  • BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20150057285
    Abstract: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
    Type: Application
    Filed: November 3, 2014
    Publication date: February 26, 2015
    Inventors: Chunlin Tao, Qinwei Wang, David Ho, Laxman Nallan, Tulay Polat, Xiaowen Sun, Neil Desai
  • Benzyl substituted triazine derivatives and their therapeutical applications
    Patent number: 8877924
    Abstract: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: November 4, 2014
    Assignee: NantBio Inc.
    Inventors: Chunlin Tao, Qinwei Wang, David Ho, Laxman Nallan, Tulay Polat, Xiaowen Sun, Neil Desai
  • Triazine derivatives and their therapeutical applications
    Patent number: 8580786
    Abstract: The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: November 12, 2013
    Assignee: Nant Holdings IP, LLC
    Inventors: Neil P. Desai, Patrick Soon-Shiong, Chunlin Tao, Qinwei Wang
  • Triazine Derivatives and their Therapeutical Applications
    Publication number: 20130023497
    Abstract: The present invention comprises inter alia triazine compounds as shown in formula (I) and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 7, 2010
    Publication date: January 24, 2013
    Inventors: Chunlin Tao, Qinwei Wang, Tulay Polat, Laxman Nallan, Neil Desai
  • BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120264759
    Abstract: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
    Type: Application
    Filed: June 8, 2010
    Publication date: October 18, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, David Ho, Laxman Nallan, Tulay Polat, Xiaowen Sun, Neil Desai
  • Triazine Derivatives and their Therapeutical Applications
    Publication number: 20120238576
    Abstract: The present invention comprises inter alia compounds as shown in formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 7, 2010
    Publication date: September 20, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Laxman Nallan, Tulay Polat, Lukasz Koroniak, Neil Desai
  • UREIDOPHENYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120202818
    Abstract: The present invention provides Uredophenyl substituted triazine derivatives and provides methods of using these compounds to modulate protein kinases and methods of using these compounds to treat protein kinase mediated diseases and conditions.
    Type: Application
    Filed: June 9, 2010
    Publication date: August 9, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Lukasz Koroniak, Laxman Nallan, Neil Desai
  • Triazine derivatives and their therapeutical applications
    Publication number: 20120196860
    Abstract: The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
    Type: Application
    Filed: June 9, 2010
    Publication date: August 2, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Laxman Nallan, Tulay Polat, David Ho, Neil Desai
  • STYRYL-TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120178758
    Abstract: The invention provides Styryl-Triazine derivatives, and further provides methods of using these compounds to modulate protein kinases and to treat protein kinase mediated diseases.
    Type: Application
    Filed: June 8, 2010
    Publication date: July 12, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Neil Desai
  • TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120172361
    Abstract: Compounds of the formula (I) and formula (II) and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 7, 2010
    Publication date: July 5, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Tulay Polat, Laxman Nallan, David Ho, Neil Desai
  • TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20110150763
    Abstract: The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.
    Type: Application
    Filed: December 17, 2010
    Publication date: June 23, 2011
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Neil P. Desai, Patrick Soon-Shiong
  • Triazine derivatives and their therapeutical applications
    Patent number: 7858782
    Abstract: The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: December 28, 2010
    Assignee: Abraxis BioScience, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Neil P. Desai, Patrick Soon-Shiong
  • DICARBONYL DERIVATIVES AND METHODS OF USE
    Publication number: 20100279963
    Abstract: Derivatives of dicarbonyl compounds having antitumor and antibiotic activity which can be used as anticancer agents.
    Type: Application
    Filed: July 1, 2010
    Publication date: November 4, 2010
    Applicant: Abraxis BioScience, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Vuong Trieu, Neil Desai, Patrick Soon-Shiong
  • Dicarbonyl derivatives and methods of use
    Patent number: 7799954
    Abstract: Derivatives of dicarbonyl compounds having antitumor and antibiotic activity which can be used as anticancer agents.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: September 21, 2010
    Assignee: Abraxis BioScience, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Vuong Trieu, Neil Desai, Patrick Soon-Shiong
  • Drugs With Improved Hydrophobicity For Incorporation in Medical Devices
    Publication number: 20090130163
    Abstract: The invention provides a medical device comprising a hydrophobic analog of a medicament known to inhibit cell proliferation and migration. The invention also provides a method of treating a narrowing in a body passageway comprising placing an implantable medical device comprising a hydrophobic analog of a medicament known to inhibit cell proliferation and migration. The medicaments can be incorporated within or coated on the device. The invention further provides hydrophobic analogs of medicaments known to inhibit cell proliferation and migration.
    Type: Application
    Filed: February 21, 2006
    Publication date: May 21, 2009
    Applicant: Abraxis Bio Scoence, Inc.
    Inventors: Neil P. Desai, Chunlin Tao, Cheng Zhi Yu, Qinwei Wang, Patrick Soon-Shiong
  • TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20080176853
    Abstract: The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.
    Type: Application
    Filed: December 14, 2007
    Publication date: July 24, 2008
    Applicant: Abraxis BioScience, Inc.
    Inventors: Chunlin Tao, Qinwei Wang, Neil P. Desai, Patrick Soon-Shiong
  • DICARBONYL DERIVATIVES AND METHODS OF USE
    Publication number: 20080146586
    Abstract: Derivatives of dicarbonyl compounds having antitumor and antibiotic activity which can be used as anticancer agents.
    Type: Application
    Filed: November 14, 2007
    Publication date: June 19, 2008
    Applicant: Abraxis BioScience
    Inventors: Chunlin Tao, Qinwei Wang, Vuong Trieu, Neil Desai, Patrick Soon-Shiong
  • Electronic device, information transfer device, information transfer method, and its program
    Publication number: 20050147377
    Abstract: Disclosed is electronic device, information transfer device, information transfer method, and its program to enable advanced booking of transfer of information whose recording has not been generated in one device and automatic transfer of the recording to another device as soon as the recording is generated. The method of the invention comprises early storing identification information for content that was set to be recorded in a given storage area at a first time; when recording of the content has finished, receiving the content identification information; comparing the early stored identification information and the received identification information for a match; if the match of the identification information is judged as the result of the comparison, storing the identification information of the match; and retrieving the content with the stored identification information from the given storage area, based on the identification information, and transferring the content to the terminal.
    Type: Application
    Filed: October 14, 2004
    Publication date: July 7, 2005
    Applicant: SONY CORPORATION
    Inventors: Rieko Kobayashi, Atsuto Ohashi, Seishi Hirao, Yoshihiro Chosokabe, Junichiro Sakata, Qinwei Wang